M34-A | Western Blot Assay for Antibodies to Borrelia burgdorferi, 1st Edition
This document addresses technical and interpretive considerations for use of Western blot assays that detect antibodies to Borrelia burgdorferi and other Borrelia species that cause Lyme Disease.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
This document is no longer being reviewed as part of our consensus process. However, because of its usefulness to a limited segment of the healthcare community, we are continuing to make the document available for its informational content.
Chairholder: Alan G. Barbour, M.D. Organization: University of California Irvine College of Medicine Date of Publication: 10/01/2000 ISBN Number: 1-56238-415-5 Format: Approved Guideline Edition: First Edition Pages: 24